#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA967651	F	Cytotoxicity against human CAL51 cells assessed as fraction of viable cells after 72 hrs relative to control	Homo sapiens	13		cell-based format	Scientific Literature
2.	ALA1762914	F	Antiproliferative activity against human CAL51 harboring PI3K/PTEN gene mutation/amplification at 1 uM after 72 hrs by Ambit assay in presence of 10% serum	Homo sapiens	1		cell-based format	Scientific Literature
3.	ALA1775247	F	Cell cycle arrest in human CAL51 cells at 0.1 to 1 uM after 24 hrs by flow cytometry	Homo sapiens	1		cell-based format	Scientific Literature
4.	ALA2363783	F	SANGER: Inhibition of human CAL-51 cell growth in a cell viability assay.	Homo sapiens	98		cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
5.	ALA3995408	A	Cytotoxicity against human CAL51 at 0.0003 to 100 uM after 48 hrs by ATPlite assay	Homo sapiens	10		cell-based format	Scientific Literature
6.	ALA4031739	F	Cytotoxicity against human CAL51 cells assessed as reduction in cell viability after 3 days by CellTiter-Glo assay	Homo sapiens	39		cell-based format	Scientific Literature
7.	ALA4031778	F	Antiproliferative activity against human CAL51 cells assessed as reduction in cell viability incubated for 12 to 72 hrs followed by compound washout measured after 72 hrs by Cell-Titer Glo assay	Homo sapiens	1		cell-based format	Scientific Literature
8.	ALA4031779	F	Antiproliferative activity against human CAL51 cells xenografted in SCID mouse assessed as tumor growth inhibition at 10 mg/kg, iv administered every 3 days for 16 days relative to control	Homo sapiens	1		organism-based format	Scientific Literature
9.	ALA4031780	F	Antiproliferative activity against human CAL51 cells xenografted in SCID mouse assessed as tumor growth inhibition at 20 mg/kg, iv administered every 3 days for 16 days relative to control	Homo sapiens	1		organism-based format	Scientific Literature
10.	ALA4031783	F	Antiproliferative activity against human CAL51 cells xenografted in SCID mouse assessed as tumor growth inhibition at 20 mg/kg, iv administered every 7 days for 16 days relative to control	Homo sapiens	1		organism-based format	Scientific Literature
11.	ALA4031788	F	Antiproliferative activity against human CAL51 cells xenografted in SCID mouse assessed as tumor growth inhibition at 5 mg/kg, iv administered every 4 days for 16 days	Homo sapiens	1		organism-based format	Scientific Literature
12.	ALA4050168	F	Antiproliferative activity against human CAL51 cells assessed as reduction in cell viability after 5 to 7 days by CellTiter 96 aqueous solution assay	Homo sapiens	5		cell-based format	Scientific Literature
13.	ALA4050206	F	Cytotoxicity against human CAL51 cells assessed as reduction in cell viability at 25 uM after 24 hrs by BrdU incorporation assay relative to control	Homo sapiens	1		cell-based format	Scientific Literature
14.	ALA4050219	F	Antitumor activity against human CAL51 cells xenografted in athymic nude mouse assessed as reduction in tumor growth at 10 mg/kg, ip administered once daily measured after 3 to 7 weeks	Homo sapiens	1		organism-based format	Scientific Literature
15.	ALA4050220	F	Antitumor activity against human CAL51 cells xenografted in athymic nude mouse assessed as reduction in tumor weight at 10 mg/kg, ip administered once daily measured after 7 weeks	Homo sapiens	1		organism-based format	Scientific Literature
16.	ALA4058369	F	Antiproliferative activity against human CAL51 cells assessed as growth inhibition after 3 days by SRB assay	Homo sapiens	19		cell-based format	Scientific Literature
17.	ALA4349090	F	Antiproliferative activity against human CAL51 cells assessed as reduction in cell viability after 3 days by CellTiter-Glo reagent-based luminescent assay	Homo sapiens	18		cell-based format	Scientific Literature
18.	ALA4349123	F	Antitumor activity against human CAL51 cells xenografted in po dosed CB17 SCID mouse assessed as tumor growth inhibition administered every seven days for 16 days and measured twice per week up to 31 days by caliper method	Homo sapiens	1		organism-based format	Scientific Literature
19.	ALA4349124	F	Antitumor activity against human CAL51 cells xenografted in CB17 SCID mouse assessed as tumor growth inhibition at 30 mg/kg, po administered every seven days for 16 days and measured twice per week up to 31 days by caliper method relative to control	Homo sapiens	1		organism-based format	Scientific Literature
20.	ALA4349125	F	Antitumor activity against human CAL51 cells xenografted in CB17 SCID mouse assessed as tumor growth inhibition at 60 mg/kg, po administered every seven days for 16 days and measured twice per week up to 31 days by caliper method relative to control	Homo sapiens	1		organism-based format	Scientific Literature